EISSN 2757-6256

TAP is categorized as Q2 in JIF. SCOPUS CITESCORE: 2.4 TAP IS INDEXED IN PUBMED

Turkish Archives of Pediatrics

60 144 2025

Graphical Abstract

HIGHLY CITED ARTICLES

Revisiting Childhood-Onset Systemic Lupus Erythematosus

Avar-Aydın and Brunner.

Familial Mediterranean Fever in Childhood

Kisla Ekinci et al.

Artificial Intelligence in Pediatrics: Learning to Walk Together

Demirbaş et al.

Infant and Young Child Feeding in Emergencies: A Narrative Review

Bilgin et al.

Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic

Şener et al.

Vasculitis in Children

Bayındır et al.

Scientific Letters

Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21

Nergis Akay ¹ , Ece Aslan ¹ , Umit Gul ¹ , Elif Kilic Konte ² , Mehmet Yildiz ¹ , Sezgin Sahin ¹

Author Affiliation(s)

1.

Department of Pediatric Rheumatology, İstanbul University-Cerrahpaşa Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye

2.

Department of Pediatric Rheumatology, İstanbul University-Cerrahpaşa Cerrahpaşa Medical Faculty, İstanbul, Türkiye

Turk Arch Pediatr 2025; 60: 695-699

DOI: 10.5152/TurkArchPediatr.2025.25394

Read: 26 Downloads: 10 Published: 03 November 2025

Volume 60, Issue 6, November 2025

Previous Article

Cite this article as: Akay N, Aslan E, Gul U, Konte EK, Yildiz M, Sahin S. Emapalumab as a life-saving therapy for macrophage activation syndrome in refractory systemic juvenile idiopathic arthritis with trisomy 21. Turk Arch Pediatr. 2025;60(6):695-699.

Files